Navigation Links
Piedmont Heart Institute Welcomes Cardiology of Georgia
Date:4/1/2008

ATLANTA, April 1, 2008 /PRNewswire/ -- Piedmont Heart Institute (PHI) expands its expertise with the addition of the 20-member cardiovascular physician practice, Cardiology of Georgia, P.C. (COG), through a formal agreement with Piedmont Healthcare effective April 1, 2008. With eight locations including Buckhead, Canton, Fayetteville and North Fulton, COG will become a new group practice under the Piedmont Heart Institute and an important addition to PHI as it continues to propel new programs in cardiovascular research, education and excellence in prevention, arrhythmias, coronary and vascular intervention, stroke and cardiac imaging.

"Cardiology of Georgia has been an integral part of the history and foundation of cardiovascular care at Piedmont for more than 30 years," said Michele M. Molden, President and CEO of the Piedmont Heart Institute. "COG will continue to serve our communities with clinical expertise and now, with involvement in the leadership and direction of the Piedmont Heart Institute."

The Piedmont Heart Institute (PHI) is the first of its kind affiliated with a community hospital system in greater Atlanta. It brings prominent cardiovascular physician groups together with one of the premier cardiac centers in the region. In fact, Piedmont Hospital was recently named Best in Atlanta for Overall Cardiac Care and Cardiac Surgery (2008) by HealthGrades(R), the leading healthcare ratings organization.

Seeking greater alignment of the physicians and our hospitals, the Piedmont Heart Institute has implemented a new care delivery model in Atlanta that eliminates the barriers to working more closely together and creates a platform where leadership is shared with enhanced care and services for the community. This fully integrated financial model will ultimately improve the patient experience, care efficiencies, quality and outcomes.

John W. Hurst Jr., M.D., managing partner of COG, said, "Piedmont has been home to us for more
'/>"/>

SOURCE Piedmont Heart Institute
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Kent Riddle Named To Piedmont Triad Biotechnology Development Group
2. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
3. ATS Medical Expands Open Pivot Heart Valve Offerings
4. Cardicas C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries
5. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
6. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
7. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
8. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
9. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
10. New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces
11. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...BOSTON,Nov.25/PRNewswire/--BiotechfirmReplikinsLtd...918pandemicthroughtheprediction,outbreak,andprogre...chemicalanalysisofthevirus.Thenewdatashowsthatthel...speakof3.7(s.d.4.5)duringthevirus,scurrentoutbreak...ekof2.0(s.d.0.1).TheH1N1virus,infectivitycount,how...
(Date:11/25/2009)...NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannoun...alogue: ,, BrazilBioethanolMarketAnalysisandFo...p0165503/Brazil-Bioethanol-Market-Analysis-and-For...nalysisandForecaststo2013 ,, Summary ,, Th...obalbioethanolmarketandtheBrazilbioethanolmarketin...
(Date:11/24/2009)... The New York investment bank KTA...NEU) has agreed an AU$6.7 mil convertible note pri... The private placement was arranged by KTA Capital.... , New York (PRWEB) Nove...nt bank KTA Capital, LLC ("KTA Capital")...
(Date:11/24/2009)... Health care employment grew by... only one to show consistent growth during the U.S...als remain in trouble, and health systems are comi...nel, instead of just administrators. , ...care employment continued growing in October despi...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
... BOSTON, Jan. 15 PAREXEL International Corporatio...tical services organization, announced today it ha...ident and Chief Information Officer (CIO). Ms. Hop...mation technology (IT) initiatives and integrating... global basis. , , Prior to joining PAREXEL, Ms. ...
... ST. LOUIS, Jan. 14 As the latest step in its..., Monsanto Company,(NYSE: MON ) today announced ...increase in the quarterly dividend on its common s...are. The dividend is payable on April 24, 2009 to,...we have often said, when farmers succeed we succee...
... LAVAL, QC, Jan. 14 /PRNewswire-FirstCall/ - BioSy...veloping biotherapeutic thermogels for regenerativ...enrolment next month for the Canadian-European piv...Gel(R). To date, the Company has enrolled more tha...l be permitted to enrol additional subjects until ...
Other Biology Technology:PAREXEL Appoints Josephine Hoppe to Chief Information Officer 2PAREXEL Appoints Josephine Hoppe to Chief Information Officer 3PAREXEL Appoints Josephine Hoppe to Chief Information Officer 4Monsanto Board Approves 10 Percent Dividend Increase 2BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 2BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 3BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 4
(Date:11/25/2009)... may be used to boost resistance to, or slow, the ... Medicine researchers report in a study published .... , Parkinson,s disease is caused by a degenerat... known as the substantia nigra, which is responsib... dopamine in late-stage Parkinson,s causes symptom...
(Date:11/25/2009)... Research Laboratory in the University of Haifa,s ...gious Johnson & Johnson Focused Funding grant for ...age in Parkinson,s disease. The award, which is gr...tion and excellence in science, was announced in 2...t an event at the Hyatt Regency Hotel in New Jerse...
(Date:11/25/2009)...ors recently received funding from the National Sc...cial to understanding the environment. The three g...ssistant professor in the Department of Biological...ate research projects. , His first project, titl...unctions from the Leaf to the Landscape," will exa...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2New Nominee for WHO Regional Director for Europe 57339 1New Nominee for WHO Regional Director for Europe 57339 2Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 1Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 2Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 3Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 4GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 1GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 2GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 3
...sts have demonstrated a new way to assess the pote...--a technique that could also be used to monitor a...isticated, noninvasive medical imaging tools. Scie...en National Laboratory, whose findings are reporte...Medicine,s Journal of Nuclear Medicine, used posit...
...s newest polymer innovation, the first DuPont poly...ognized by the China State Intellectual Property O... Visionary Innovation" at a recent award ceremony....ive the 2005 "New Technologies in Renewable Materi...d Environmental Conference, sponsored by the Socie...
...e sclerosis (MS) can be an unpredictable disease. ...healthy nerve cells and disrupts normal nerve sign...s—including tingling, paralysis, pain, fatigue, an...in combination, sporadically or persistently. Alth...-ups are common in the majority of patients. , MS...
Other Biology News:PET/MRI scans may help unravel mechanisms of prenatal drug damage 2PET/MRI scans may help unravel mechanisms of prenatal drug damage 3PET/MRI scans may help unravel mechanisms of prenatal drug damage 4DuPont's first biologically derived polymer receives global recognition 2Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients 2
Customized Competent E. coli. from Molecular Cloning Laboratories (MCLAB)
Fluorescent Standards Red Standard from Invitrogen
X-Gal from GE Healthcare, formerly Amersham Biosciences
Mouse Anti-Oligodendrocyte Marker O1 Monoclonal Antibody, Unconjugated, Clone O1 from R&D Systems
Biology Products: